论文部分内容阅读
阿斯匹林能有效地抑制血小板聚集,是广泛用于预防和治疗缺血性心脑血管疾病的药物之一。然而有相当多的患者服用阿斯匹林后仍会再发血管事件,其血小板未被抑制或未被充分抑制,这种现象称为“阿斯匹林抵抗(aspirinresistance,AR)”。本文将讨论AR的流行病学、产生机制、实验室检
Aspirin can effectively inhibit platelet aggregation and is widely used in the prevention and treatment of ischemic cardiovascular and cerebrovascular diseases. However, a considerable number of patients who have taken aspirin still have recurrent vascular events whose platelets have not been suppressed or are not adequately inhibited, a phenomenon known as aspirin resistance (AR). This article will discuss the epidemiology, mechanism of AR, laboratory tests